Heartburn and the Holidays: Zantac’s Link to Cancer

Heartburn and the Holidays: Zantac’s Link to Cancer

December 27, 2019 | Napoli Shkolnik News

Zantac And Cancer: The Popular Antacid Found to Have a Known Carcinogen for Possibly Decades

If you’re reaching for that heartburn medication during all this holiday eating, watch out! Recent headlines have been exposing the popular antacid Zantac for having a possible link to cancer after investigations by the FDA detected ‘unacceptable amounts’ of a possible carcinogen in the ranitidine medication.

While this popular drug seems to harmlessly treat heartburn, recent research suggests that it might be linked to cancer because of the carcinogen detected in the drug. The manufacturer of this popular heartburn product has since voluntarily recalled Zantac products as investigations regarding their link to cancer continue.

When Was this Discovery Made?

In September of this year, the link between Zantac and cancer was discovered as the result of recent research on NDMA (N-nitrosodimethylamine). When the FDA discovered that Zantac contains NDMA, the drug was taken off the shelves of popular pharmacies such as CVS and Walmart and voluntarily recalled by the manufacturer, Sanofi.

The standard version of Zantac found in many major stores is called ranitidine, which was recalled in October. This happened very quickly and very recently, so it’s wise to stop using either Zantac or ranitidine if you have either of those products in your household.

What Are the Effects of Carcinogens in the Antacid?

As mentioned, a carcinogen is anything that leads to the formation of cancer. Due to the large amounts of NDMA in ranitidine, the FDA considered Zantac products unsafe because of its ability to potentially cause cancer.

While it hasn’t been empirically proven that Zantac causes cancer directly, there’s a significant possibility that the carcinogenic ingredient (NDMA) in the drug could lead to health problems.

How Are Zantac Users Responding?

Since the FDA notified the public about the carcinogen detected in Zantac, numerous consumers who believe their use of the drug caused cancer are taking legal action. The probable carcinogen NDMA is associated with a number of cancers affecting different parts of the body, including the lungs, pancreas, kidney, and liver.

Again, whilst there is still no conclusive evidence that these NDMA-containing heartburn products will cause cancer, there is a strong enough potential link between cancer-causing drugs and ranitidine. Because of this, several users who have developed cancer since taking this medication have filed successful lawsuits against Zantac and ranitidine manufacturers.

How Napoli Shkolnik Can Help

If you or a loved one has taken Zantac and now suffer from cancer, you should investigate your legal options. At Napoli Shkolnik, our experienced pharmaceutical lawyers can help you get the compensation you deserve.

We understand that such a health concern can cause undue financial and emotional stress, and manufacturers should not be left without the responsibility of compensating those whose lives have been severely impacted by Zantac and ranitidine-containing products. Contact us today to see how our attorneys at Napoli Shkolnik can assist you by assessing your case and developing a legal plan to get you the closure you need, both financially and emotionally.

Share This:
CATEGORY: Napoli Shkolnik News

How Can We Help?

Do you need assistance with a legal matter? Our attorneys have the experience needed to guide you in the right direction.